The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.
A. Ari Hakimi
No relevant relationships to disclose
Irina Ostrovnaya
No relevant relationships to disclose
Anders Jacobsen
No relevant relationships to disclose
Jonathan A. Coleman
No relevant relationships to disclose
Paul Russo
No relevant relationships to disclose
Roy Mano
No relevant relationships to disclose
Alexander Sankin
No relevant relationships to disclose
Robert John Motzer
No relevant relationships to disclose
Mark Purdue
No relevant relationships to disclose
Mark Pomerantz
No relevant relationships to disclose
Matthew L Freedman
No relevant relationships to disclose
Toni K. Choueiri
No relevant relationships to disclose
James Hsieh
No relevant relationships to disclose
Robert J. Klein
No relevant relationships to disclose